ESG Weight-Loss Procedure More Effective And Cheaper Than Ozempic

A new study in JAMA shows the cost of semaglutide would need to drop three-fold to equal ESG, a quick procedure that helps patients lose up to 18-20% of their weight.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news